Author

Yalçin K

Dicle

Biography

Dr.  Yalçin K is currently working in Department of Gastroenterology, Dikle University, Diyarbak?r, Turkey. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta
B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ...Hepatology 60 (1), 87-97, 2014201
281
2014
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ...The Lancet infectious diseases 19 (3), 275-286, 2019201
135
2019
Anti-HDV IgM as a marker of disease activity in hepatitis delta
A Wranke, B Heidrich, S Ernst, B Calle Serrano, FA Caruntu, MG Curescu, ...PLoS One 9 (7), e101002, 2014201
73
2014
Association between level of hepatitis D virus RNA at week 24 of pegylated interferon therapy and outcome
O Keskin, H Wedemeyer, A Tüzün, K Zachou, X Deda, GN Dalekos, ...Clinical Gastroenterology and Hepatology 13 (13), 2342-2349. e2, 2015201
67
2015
HCC with low-and normal-serum alpha-fetoprotein levels
BI Carr, H Akkiz, O Üsküdar, K Yalçın, V Guerra, S Kuran, ...Clinical practice (London, England) 15 (1), 453, 2018201
54
2018
Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta
A Wranke, S Hardtke, B Heidrich, G Dalekos, K Yalçin, F Tabak, S Gürel, ...Journal of Viral Hepatitis 27 (12), 1359-1368, 2020202
39
2020
Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis
B Yilmaz, S Koklu, H Buyukbayram, K Yalçin, U Korkmaz, E Posul, G Can, ...African health sciences 15 (3), 714-718, 2015201
37
2015
Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: results from the HIDIT‐II study
B Bremer, OE Anastasiou, S Hardtke, FA Caruntu, MG Curescu, K Yalcin, ...Liver International 41 (2), 295-299, 2021202
26
2021
Macroscopic portal vein thrombosis in HCC patients
H Akkiz, BI Carr, S Kuran, Ü Karaoğullarından, O Üsküdar, S Tokmak, ...Canadian Journal of Gastroenterology and Hepatology 2018, 2018201
24
2018
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics
A Suner, BI Carr, H Akkiz, O Uskudar, S Kuran, Y Tokat, S Tokmak, T Ballı, ...Journal of translational science 5 (3), 2019201
22
2019
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors
BI Carr, H Akkiz, V Guerra, O Üsküdar, S Kuran, Ü Karaoğullarından, ...Clinical practice (London, England) 15 (Spec Issue), 625, 2018201
21
2018
Interleukin‐28 gene polymorphisms may contribute to HB sAg persistence and the development of HB eAg‐negative chronic hepatitis B
SC Karataylı, M Bozdayı, E Karataylı, T Öztürk, AA Husseini, R Albayrak, ...Liver International 35 (3), 846-853, 151
20
2015
Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
H Akkiz, BI Carr, HG Bag, Ü Karaoğullarından, K Yalçın, N Ekin, ...International journal of clinical practice 75 (2), e13593, 2021202
19
2021
C-reactive protein and platelet-lymphocyte ratio as potential tumor markers in low-alpha-fetoprotein hepatocellular carcinoma
A Suner, BI Carr, H Akkiz, G Karakülah, O Üsküdar, K Yalçın, S Kuran, ...Oncology 96 (1), 25-32, 2018201
15
2018
Cholestasis caused by Fasciola gigantica
R Bestas, K Yalçin, M ÇiçekTürkiye Parazitolojii Dergisi 38 (3), 201, 2014201
13
2014
Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta
G Kabaçam, H Wedemeyer, B Savaş, O Keskin, G Dalekos, F Tabak, ...Liver International 34 (8), 1207-1215, 2014201
9
2014
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis
BI Carr, H Akkiz, HG Bag, U Karaoğullarından, K Yalçın, N Ekin, ...Journal of translational science 7 (3), 2021202
6
2021
Perkutan endoskopik gastrostomi uygulama sonuçlarımız: 113 olgunun değerlendirilmesi
E Nazım, F Uçmak, O Menduh, E Tuncer, K YalçinDicle Tıp Dergisi 42 (3), 346-349, 20120
5
2015
Erythrocyte sedimentation rate and C-reactive protein are markers for tumor aggressiveness and survival in patients with hepatocellular carcinoma
B Carr, H Akkiz, V Guerra, R Donghia, K Yalcin, U Karaogullarindan, ...Journal of Clinical Trials 10 (5), 1-11, 2020202
4
2020
A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction
OE Anastasiou, C Yurdaydin, B Maasoumy, S Hardtke, FA Caruntu, ...Journal of Viral Hepatitis 28 (2), 10-19, 2021202
4
2021

Referred From: https://scholar.google.com/citations?hl=en&user=CPmrV4cAAAAJ

Cited by
Citations 2321
h-index 26
i10-index 44
Recommended Journals
Open Access Journals